Hematology Oncology Assoc Chicago, IL - 60611

Hematology Oncology Assoc is categorized under Hematologists in Chicago, IL and active since 1990.

Hematology Oncology Assoc was established in 1990, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6219992 by the NAICS.

If you are seeking more information, feel free to contact Jamie Castro, Manager at the company’s single location by writing to 676 North Saint Clair St # 2140, Chicago, Illinois IL 60611 or by phoning (312) 664-5400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Hematology Oncology Assoc
Contact Person: Jamie Castro, Manager
Address: 676 North Saint Clair St # 2140, Chicago, Illinois 60611
Phone Number: (312) 664-5400
Website Address: usoncology.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 1990
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Hematologists
SIC Code: 8011
NAICS Code: 6219992
Share This Business:

Hematology Oncology Assoc was started in 1990 to provide professional Hematologists under the SIC code 8011 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Jamie Castro, Manager for inquiries that concern Hematology Oncology Assoc by calling the company number (312) 664-5400, as your correspondence is most welcome. Additionally, the physical location of the single location of Hematology Oncology Assoc can be found at the coordinates 41.894504,-87.622814 as well as the street address 676 North Saint Clair St # 2140 in Chicago, Illinois 60611.

For its online presence, you may visit Hematology Oncology Assoc’s website at usoncology.com and engage with its social media outlets through on Twitter and on Facebook.